Oral diabetic therapy in type 2 diabetes mellitus

Mariusz Jasik; Krzysztof Dęmbe; Waldemar Karnafel

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors

3/2005
vol. 8

Send email

Copy url:

abstract:

Oral diabetic therapy in type 2 diabetes mellitus

Mariusz Jasik

,

Krzysztof Dęmbe

,

Waldemar Karnafel

Przew Lek 2005; 3: 74-80

Online publish date: 2005/05/05

View full text Get citation

The aim of article is to review the various therapeutic agents available for management of patients with type 2 diabetes and to suggest an approach to drug selection as monotherapy and in combination theraphy. There are now five classes of oral medications which are available in therapy of type 2 diabetes – sulfonylureas, glinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors. Each class of drugs works differently to treat impaired insulin secretion, insulin resistance and postprandial hyperglycemia. Application of the strategies and principles of oral diabetic therapy in type 2 diabetes should be individualised based on the degree of hyperglycemia, hyperinsulinemia or insulin deficiency.

keywords:

Oral diabetic therapy in type 2 diabetes mellitus

Mariusz Jasik , Krzysztof Dęmbe , Waldemar Karnafel

type 2 diabetes mellitus, pharmacologic therapy

Mariusz Jasik

,

Krzysztof Dęmbe

,

Waldemar Karnafel